Diffuse Large B-Cell Lymphoma CD20 antigen positive
Item
histologically confirmed, cd20 positive, diffuse large b-cell lymphoma (dlcl)
boolean
C0079744 (UMLS CUI [1,1])
C3888518 (UMLS CUI [1,2])
Measurable Disease
Item
measurable disease according to international criteria
boolean
C1513041 (UMLS CUI [1])
Gender
Item
male or female
boolean
C0079399 (UMLS CUI [1])
Age
Item
age 18 years and above
boolean
C0001779 (UMLS CUI [1])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Myocardial Infarction
Item
myocardial infarction within 6 months prior to study entry
boolean
C0027051 (UMLS CUI [1])
Heart failure New York Heart Association Classification
Item
cardiac insufficiency nyha grade 3 or 4
boolean
C0018801 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
Chemotherapy | Therapeutic radiology procedure
Item
previous treatment with chemotherapy or radiotherapy
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
Central Nervous System Involvement
Item
cns involvement of the disease
boolean
C4050309 (UMLS CUI [1])
HIV Seropositivity
Item
positive for hiv
boolean
C0019699 (UMLS CUI [1])
WHO performance status scale
Item
who performance index 3 or 4
boolean
C1298650 (UMLS CUI [1])
Secondary Neoplasm
Item
secondary malignoma
boolean
C2939419 (UMLS CUI [1])
Comorbidity Preventing Chemotherapy
Item
concurrent disease that prohibits chemotherapy
boolean
C0009488 (UMLS CUI [1,1])
C1292733 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,3])
Hypersensitivity Intervention Investigational | Hypersensitivity Component Intervention Investigational
Item
known hypersensitivity towards the study interventions or their constituents
boolean
C0020517 (UMLS CUI [1,1])
C0184661 (UMLS CUI [1,2])
C1517586 (UMLS CUI [1,3])
C0020517 (UMLS CUI [2,1])
C1705248 (UMLS CUI [2,2])
C0184661 (UMLS CUI [2,3])
C1517586 (UMLS CUI [2,4])
Neutropenia | Thrombocytopenia
Item
neutropenia or thrombopenia
boolean
C0027947 (UMLS CUI [1])
C0040034 (UMLS CUI [2])